Systematic Review with Meta-Analysis: Alcohol Consumption and Risk of Colorectal Serrated Polyp

Digestive Diseases and Sciences

Volumn 60, Issue 7, 2015, Pages 1889-1902

  Wang, Yu Ming ^a   Zhou, Qin Yi ^b   Zhu, Jin Zhou ^a   Zhu, Ke Fu ^c   Yu, Chao Hui ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Alcohol; Colorectal cancer; Colorectal serrated polyp; Hyperplastic polyp; Meta analysis; Serrated adenoma

Indexed keywords

ALCOHOL CONSUMPTION; ASIA; CASE CONTROL STUDY; COHORT ANALYSIS; COLORECTAL POLYP; COLORECTAL SERRATED POLYP; CROSS-SECTIONAL STUDY; EUROPE; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNITED STATES; ADVERSE EFFECTS; CHEMICALLY INDUCED; CLASSIFICATION; COLON POLYP; DOSE RESPONSE; DRINKING BEHAVIOR;

ALCOHOL DRINKING; COLONIC POLYPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; RISK FACTORS;

EID: 84930823595     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3518-3     Document Type: Review

References (46)

1. Boyle P, Langman JS. ABC of colorectal cancer: epidemiology. BMJ. 2000;321:805–808.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917.
3. Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009;136:832–841.
4. Cottet V, Jooste V, Fournel I, et al. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut. 2012;61:1180–1186.
5. Rosty C, Hewett DG, Brown IS, et al. Serrated polyps of the large intestine: current understanding of diagnosis, pathogenesis, and clinical management. J Gastroenterol. 2013;48:287–302.
6. Carr NJ, Mahajan H, Tan KL, et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62:516–518.
7. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131:1400–1407.
8. Goldstein NS, Bhanot P, Odish E, et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol. 2003;119:778–796.
9. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32–40.
10. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–1329; quiz 1314, 1330.
11. Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol. 2010;63:681–686.
12. Erhardt JG, Kreichgauer HP, Meisner C, Bode JC, Bode C. Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps—a case control study. Eur J Nutr. 2002;2002:35–43.
13. Kearney J, Giovannucci E, Rimm EB, et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control. 1995;6:45–56.
14. Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–772.
15. Stern MC, Siegmund KD, Conti DV, et al. XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomark Prev. 2006;15:2384–2390.
16. Peipins LA, Sandler RS. Epidemiology of colorectal adenomas. Epidemiol Rev. 1994;16:273–297.
17. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003;290:2959–2967.
18. Morimoto LM, Newcomb PA, Ulrich CM, et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomark Prev. 2002;11:1012–1018.
19. Shrubsole MJ, Wu H, Ness RM, et al. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol. 2008;167:1050–1058.
20. Martinez ME, McPherson RS, Levin B, et al. A case–control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology. 1997;113:423–429.
21. Bingham SA. Diet and large bowel cancer. J R Soc Med. 1990;83:420–422.
22. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1–e34.
23. Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
24. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
25. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
26. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589–624.
27. Bagnardi V, Zambon A, Quatto P, et al. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159:1077–1086.
28. Ulrich CM, Kampman E, Bigler J, et al. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol Biomark Prev. 2000;9:427–433.
29. Jung AY, Poole EM, Bigler J, et al. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomark Prev. 2008;17:330–338.
30. Burnett-Hartman AN, Passarelli MN, Adams SV, et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol. 2013;177:625–637.
31. Hassan C, Pickhardt PJ, Marmo R, et al. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum. 2010;53:1328–1333.
32. Wang FW, Hsu PI, Chuang HY, et al. Prevalence and risk factors of asymptomatic colorectal polyps in Taiwan. Gastroenterol Res Pract. 2014;2014:985205.
33. Hawkins NJ, Ward RL. Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas. J Natl Cancer Inst. 2001;93:1307–1313.
34. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088–2100.
35. Huang CS, O’Brien MJ, Yang S, et al. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol. 2004;99:2242–2255.
36. Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.
37. Torlakovic E, Skovlund E, Snover DC, et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol. 2003;27:65–81.
38. O’Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491–1501.
39. Baker K, Zhang Y, Jin C, et al. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol. 2004;57:1089–1093.
40. Issa JP. The epigenetics of colorectal cancer. Ann N Y Acad Sci. 2000;910:140–153; discussion 153–155.
41. Torlakovic E, Snover DC. Sessile serrated adenoma: a brief history and current status. Crit Rev Oncog. 2006;12:27–39.
42. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst. 2000;92:1831–1836.
43. Limsui D, Vierkant RA, Tillmans LS, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst. 2010;102:1012–1022.
44. Campbell PT, Jacobs ET, Ulrich CM, et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst. 2010;102:391–400.
45. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132:2350s–2355s.
46. Acott AA, Theus SA, Marchant-Miros KE, et al. Association of tobacco and alcohol use with earlier development of colorectal cancer: Should we modify screening guidelines? Am J Surg. 2008;196:915–918; discussion 918–919.